Abstract:Objective To develop an LC-MS/MS method for simultaneous determine the concentration of atorvastatin (AT) and its two active metabolites,ortho-hydmxyatorvastatin (o-AT) andpara-hydroxyatorvastatin (p-AT) in human plasma.Methods Deuterium-labeled compounds,o-AT-d5 and p-AT-d5were used as the internal standards.The analytes were extracted from human plasma through liquid liquid extraction method by using tert-butyl ether,after adding 5％ formic acid.The chromatographic separation was achieved on a CAPCELL PAK C18(2.0 mm× 100 mm,TYPE∶MG Ⅱ,5 μm) column with the mobile phase,consisted of a mixture of acetonitrile-5 mmol · L-1 ammonium acetate buffer-formic acid (46∶ 54∶ 0.143,v/v/v),in isocratic mode at a flow rate of 0.40 mL · min-1.Data acquisition was carried out in multiple reaction monitoring (MRM) mode.Analytes were detected on a tandem mass spectrometer,equipped with an electrospray ionization source that was operated in the positive mode,using the transitions of m/z 559.3→m/z 440.2 for atorvastatin,and m/z 575.3→m/z 440.2 for both ortho-and para-hydroxyatorvastatin.The selectivity,standard curve,precision and accuracy,extraction recoveries,matrix effect,carry over and stability were investigated.Results The linear range of atorvastatin was 0.05-100 ng · mL-1.The linear regression equation was y =4.35 × 10-2x + 3.43 × 10-4 (r =0.999 3) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The linear range of ortho-atorvastatin was 0.05-50 ng· mL-1.The linear regression equation was y =1.03 × 10-1x + 6.93 × 10-4 (r =0.998 7) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The linear range of para-atorvastatin was 0.05-5.0 ng · mL-1.The linear regression equation was y =5.35 × 10-1 x-2.26 × 10-3 (r =0.998 4) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The intra-day and inter-day relative standard deviations (RSD) of LLOQ,low,medium1,medium2 and high concentrations of atorvastatin were both less than 15％.The extraction recoveries were 61.64％-90.29％.The matrix effects were 88.74％-105.62％.Conclusion The established method is rapid,sensitive,accurate,specific and reliable,and suitablefor simultaneous determination of atorvastatin and its active metabolites (ortho-atorvastatin and para-atorvastatin) in human plasma,which meets the needs of clinical therapeutic drug monitoring and pharmacokinetics research.

Simultaneous determination of Obeticholic acid and its two major metabolites in human plasma after administration of Obeticholic acid tablets using ultra-high performance liquid chromatography tandem mass spectrometry

Obeticholic Acid—A Pharmacological and Clinical Review

An ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of obeticholic acid in rat plasma and its application in preclinical pharmacokinetic studies

A Sensitive HPLC-MS/MS Method for Determination of Obeticholic Acid in Human Plasma: Application to a Pharmacokinetic Study in Healthy Volunteers

Analysis of Ochratoxin A and Ochratoxin B in Traditional Chinese Medicines by Ultra-High-performance Liquid Chromatography–tandem Mass Spectrometry Using [13C20]-Ochratoxin A As an Internal Standard

Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry.

A Rapid UPLC-MS/MS Method for the Determination of Oleanolic Acid in Rat Plasma and Liver Tissue: Application to Plasma and Liver Pharmacokinetics.

High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma.

Simultaneous determination of atorvastatin and its active metabolites in human plasma by LC-MS/MS

Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects under Fasting and Fed Conditions.

High-Throughput Determination of Carbocysteine in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry: Application to A Bioequivalence Study of Two Formulations in Healthy Volunteers

Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS method

Simultaneous Determination Of Baicalein And Baicalin In Human Plasma By High Performance Liquid Chromatograph-Tandem Spectrometry And Its Application In A Food-Effect Pharmacokinetic Study

Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry

Determination of ursodeoxycholic acid in human plasma by liquid chromatography tandem mass spectrometry

Development and validation of a liquid chromatography–tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study

Establishment and preliminary clinical application of serum bile acid spectrum analysis by ultra high

Combinatorial Approach of Lc-Ms/Ms and Lc-Tof-Ms for Uncovering in Vivo Kinetics and Biotransformation of Ochratoxin A in Rat

Separation of bile acid isomer plays a pivotal role in bioequivalence evaluation of ursodeoxycholic acid

Simultaneous quantitative determination of paracetamol and its glucuronide conjugate in human plasma and urine by liquid chromatography coupled to electrospray tandem mass spectrometry: Application to a clinical pharmacokinetic study

Development of a LC-MS/MS Method for a New Ortho-aryl Chalcone Compound of OC26 and its Application to Bile